Kalpit Patel
Stock Analyst at Wolfe Research
(0.98)
# 3,900
Out of 5,056 analysts
69
Total ratings
37.21%
Success rate
-11.43%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Kalpit Patel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ORIC ORIC Pharmaceuticals | Initiates: Peer Perform | n/a | $11.70 | - | 1 | Nov 18, 2025 | |
| CORT Corcept Therapeutics | Initiates: Peer Perform | n/a | $74.70 | - | 1 | Nov 18, 2025 | |
| JANX Janux Therapeutics | Initiates: Peer Perform | n/a | $28.97 | - | 1 | Nov 18, 2025 | |
| TNGX Tango Therapeutics | Initiates: Peer Perform | n/a | $8.20 | - | 1 | Nov 18, 2025 | |
| ACLX Arcellx | Initiates: Peer Perform | n/a | $89.92 | - | 1 | Nov 18, 2025 | |
| SMMT Summit Therapeutics | Initiates: Peer Perform | n/a | $16.40 | - | 1 | Nov 18, 2025 | |
| SRRK Scholar Rock Holding | Initiates: Outperform | $42 | $39.72 | +5.74% | 1 | Nov 18, 2025 | |
| SLNO Soleno Therapeutics | Initiates: Outperform | $75 | $47.85 | +56.74% | 1 | Nov 18, 2025 | |
| RVMD Revolution Medicines | Initiates: Outperform | $75 | $70.59 | +6.25% | 1 | Nov 18, 2025 | |
| CELC Celcuity | Initiates: Outperform | $110 | $92.07 | +19.47% | 1 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $12 | $7.67 | +56.45% | 6 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $38 → $60 | $64.72 | -7.29% | 5 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $17 → $14 | $6.31 | +121.88% | 7 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $37 | $20.09 | +84.17% | 1 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $24 | $42.60 | -43.66% | 6 | Mar 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5.5 → $3.5 | $1.07 | +228.64% | 4 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $7 → $9 | $9.21 | -2.28% | 4 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $4.94 | +102.43% | 1 | Jan 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $0.76 | +827.15% | 5 | Nov 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $85 → $40 | $11.81 | +238.70% | 2 | Sep 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $3 | $1.28 | +134.38% | 2 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $25 → $20 | $28.64 | -30.17% | 3 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $90 → $30 | $3.53 | +749.86% | 1 | Dec 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $36 | $16.87 | +113.40% | 2 | Jul 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $270 → $90 | $1.63 | +5,421.47% | 3 | Nov 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $21 → $18 | $1.25 | +1,345.78% | 2 | Sep 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $5 | $2.67 | +87.27% | 2 | Jul 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $100 | $10.83 | +823.79% | 1 | Jan 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $75 | $19.56 | +283.44% | 2 | Sep 3, 2021 |
ORIC Pharmaceuticals
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $11.70
Upside: -
Corcept Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $74.70
Upside: -
Janux Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $28.97
Upside: -
Tango Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $8.20
Upside: -
Arcellx
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $89.92
Upside: -
Summit Therapeutics
Nov 18, 2025
Initiates: Peer Perform
Price Target: n/a
Current: $16.40
Upside: -
Scholar Rock Holding
Nov 18, 2025
Initiates: Outperform
Price Target: $42
Current: $39.72
Upside: +5.74%
Soleno Therapeutics
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $47.85
Upside: +56.74%
Revolution Medicines
Nov 18, 2025
Initiates: Outperform
Price Target: $75
Current: $70.59
Upside: +6.25%
Celcuity
Nov 18, 2025
Initiates: Outperform
Price Target: $110
Current: $92.07
Upside: +19.47%
Jul 30, 2025
Maintains: Buy
Price Target: $9 → $12
Current: $7.67
Upside: +56.45%
Jun 3, 2025
Upgrades: Buy
Price Target: $38 → $60
Current: $64.72
Upside: -7.29%
May 2, 2025
Maintains: Neutral
Price Target: $17 → $14
Current: $6.31
Upside: +121.88%
Mar 20, 2025
Initiates: Buy
Price Target: $37
Current: $20.09
Upside: +84.17%
Mar 5, 2025
Maintains: Neutral
Price Target: $20 → $24
Current: $42.60
Upside: -43.66%
Feb 18, 2025
Maintains: Buy
Price Target: $5.5 → $3.5
Current: $1.07
Upside: +228.64%
Jan 31, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $9.21
Upside: -2.28%
Jan 30, 2025
Initiates: Buy
Price Target: $10
Current: $4.94
Upside: +102.43%
Nov 25, 2024
Maintains: Buy
Price Target: $9 → $7
Current: $0.76
Upside: +827.15%
Sep 20, 2024
Maintains: Buy
Price Target: $85 → $40
Current: $11.81
Upside: +238.70%
Jun 18, 2024
Maintains: Buy
Price Target: $9 → $3
Current: $1.28
Upside: +134.38%
May 9, 2024
Downgrades: Neutral
Price Target: $25 → $20
Current: $28.64
Upside: -30.17%
Dec 12, 2023
Downgrades: Neutral
Price Target: $90 → $30
Current: $3.53
Upside: +749.86%
Jul 25, 2023
Maintains: Buy
Price Target: $34 → $36
Current: $16.87
Upside: +113.40%
Nov 11, 2022
Downgrades: Neutral
Price Target: $270 → $90
Current: $1.63
Upside: +5,421.47%
Sep 22, 2022
Maintains: Buy
Price Target: $21 → $18
Current: $1.25
Upside: +1,345.78%
Jul 19, 2022
Maintains: Buy
Price Target: $6 → $5
Current: $2.67
Upside: +87.27%
Jan 24, 2022
Maintains: Buy
Price Target: $240 → $100
Current: $10.83
Upside: +823.79%
Sep 3, 2021
Downgrades: Neutral
Price Target: $75
Current: $19.56
Upside: +283.44%